Trial Profile
Evaluation of efficacy and tolerability of switching to ziprasidone from other antipsychotic medications
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 03 May 2008 Status changed from in progress to completed.
- 22 Oct 2007 The expected completion date for this trial is now 1 Dec 2008.
- 17 Apr 2007 New trial record.